Transamerica Financial Advisors LLC Makes New $7.20 Million Investment in Cardinal Health, Inc. $CAH

Transamerica Financial Advisors LLC bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 30,315 shares of the company’s stock, valued at approximately $7,202,000.

Other hedge funds have also recently made changes to their positions in the company. University of Texas Texas AM Investment Management Co. purchased a new stake in Cardinal Health in the 4th quarter valued at about $26,000. Bank of Jackson Hole Trust purchased a new stake in shares of Cardinal Health in the fourth quarter valued at approximately $27,000. Jones Financial Companies Lllp grew its stake in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares in the last quarter. Palladiem LLC purchased a new position in Cardinal Health during the 4th quarter worth $28,000. Finally, Indiana Trust & Investment Management Co bought a new position in shares of Cardinal Health during the 1st quarter worth $29,000. 87.17% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

CAH has been the subject of several recent research reports. Wells Fargo & Company lifted their price objective on Cardinal Health from $245.00 to $277.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Weiss Ratings lowered shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a report on Wednesday, August 19th. Evercore reaffirmed an “outperform” rating and issued a $270.00 price target on shares of Cardinal Health in a research report on Wednesday, August 12th. Bank of America increased their price objective on shares of Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a research note on Thursday, July 2nd. Finally, Leerink Partners set a $292.00 price target on Cardinal Health in a report on Tuesday, August 11th. Sixteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and an average price target of $266.56.

Insider Activity

In other Cardinal Health news, CEO Deborah Weitzman sold 7,354 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $235.45, for a total value of $1,731,499.30. Following the completion of the sale, the chief executive officer owned 77,901 shares of the company’s stock, valued at approximately $18,341,790.45. This trade represents a 8.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Michelle D. Greene sold 11,650 shares of the company’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $235.72, for a total transaction of $2,746,138.00. Following the transaction, the insider owned 10,330 shares in the company, valued at approximately $2,434,987.60. This trade represents a 53.00% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 210,271 shares of company stock worth $49,626,657 over the last quarter. Company insiders own 0.12% of the company’s stock.

Cardinal Health Stock Up 0.3%

NYSE CAH opened at $238.61 on Thursday. The firm has a market cap of $55.50 billion, a PE ratio of 33.00, a price-to-earnings-growth ratio of 1.43 and a beta of 0.49. The company has a 50 day moving average price of $232.59 and a 200 day moving average price of $218.25. Cardinal Health, Inc. has a 52 week low of $145.87 and a 52 week high of $258.30.

Cardinal Health (NYSE:CAH) last posted its earnings results on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, beating analysts’ consensus estimates of $2.42 by $0.49. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The company had revenue of $63.67 billion during the quarter, compared to analysts’ expectations of $65.15 billion. During the same quarter in the prior year, the company posted $2.08 earnings per share. Cardinal Health’s revenue for the quarter was up 5.8% compared to the same quarter last year. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 12.55 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be given a $0.5158 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is presently 28.49%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.